The 79th World Health Assembly opened in Geneva, Switzerland, on May 18, 2026 [1], under the theme “Reshaping global health: a shared responsibility” [2].
The summit arrives as international aid declines, forcing a shift toward sovereign capacity and equity to ensure nations can manage health crises without total dependence on foreign assistance.
World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus opened the proceedings by emphasizing the need for organizational evolution. “For us, change is a constant, and we will continue to change — not for the sake of change, but for the sake of the countries and people we serve,” Tedros said [3].
President John Dramani Mahama advocated for a fundamental shift in how global health is managed. He said the world needs a new global health order anchored on self-reliance, equity, and sovereign capacity [4]. This push for reform is linked to the "Accra Reset," an initiative aimed at driving systemic changes in global health governance [5].
Union Health Minister JP Nadda also attended the assembly, noting that the event brings together health ministers and experts from more than 165 countries [6]. Nadda said the participants will discuss the theme of shared responsibility to improve global preparedness [6].
The assembly is scheduled to run from May 18 to May 23, 2026 [7]. Throughout the week, delegates will address the gap between wealthy and developing nations' health infrastructures, a disparity that was highlighted during previous global pandemics.
By focusing on self-reliance, the assembly seeks to move away from a donor-dependent model toward one where countries build their own sustainable medical manufacturing, and distribution networks [4].
““For us, change is a constant, and we will continue to change – not for the sake of change, but for the sake of the countries and people we serve.””
The emphasis on 'sovereign capacity' and 'self-reliance' marks a strategic pivot in global health policy. As traditional international aid fluctuates, the WHO is encouraging member states to develop independent pharmaceutical and diagnostic capabilities. This shift aims to reduce the vulnerability of developing nations to supply chain disruptions and the political priorities of donor countries.
